Inlay Matthew A, Bhattacharya Deepta, Sahoo Debashis, Serwold Thomas, Seita Jun, Karsunky Holger, Plevritis Sylvia K, Dill David L, Weissman Irving L
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
Genes Dev. 2009 Oct 15;23(20):2376-81. doi: 10.1101/gad.1836009.
Common lymphoid progenitors (CLPs) clonally produce both B- and T-cell lineages, but have little myeloid potential in vivo. However, some studies claim that the upstream lymphoid-primed multipotent progenitor (LMPP) is the thymic seeding population, and suggest that CLPs are primarily B-cell-restricted. To identify surface proteins that distinguish functional CLPs from B-cell progenitors, we used a new computational method of Mining Developmentally Regulated Genes (MiDReG). We identified Ly6d, which divides CLPs into two distinct populations: one that retains full in vivo lymphoid potential and produces more thymocytes at early timepoints than LMPP, and another that behaves essentially as a B-cell progenitor.
常见淋巴祖细胞(CLP)可克隆产生B细胞和T细胞谱系,但在体内几乎没有髓系分化潜能。然而,一些研究称上游淋巴系定向多能祖细胞(LMPP)是胸腺播种群体,并表明CLP主要受B细胞限制。为了鉴定能够区分功能性CLP与B细胞祖细胞的表面蛋白,我们使用了一种新的挖掘发育调控基因(MiDReG)的计算方法。我们鉴定出Ly6d,它将CLP分为两个不同群体:一个群体保留了完整的体内淋巴分化潜能,在早期比LMPP产生更多胸腺细胞;另一个群体本质上表现为B细胞祖细胞。